翔宇医疗：2025年营收增3.26%，净利润降23.55%

Core Insights - The company reported a total operating revenue of 767.75 million yuan for the fiscal year 2025, representing a year-on-year growth of 3.26% [1] - The net profit attributable to the parent company was 78.70 million yuan, showing a year-on-year decrease of 23.55% [1] - The net profit after deducting non-recurring gains and losses was 58.95 million yuan, reflecting a year-on-year decline of 34.48% [1] Financial Performance - Total assets at the end of the reporting period amounted to 3.27 billion yuan, which is an increase of 11.64% year-on-year [1] - The equity attributable to the parent company's shareholders reached 2.07 billion yuan, marking a year-on-year increase of 1.54% [1] - The changes in performance were primarily attributed to increased expenses related to R&D personnel salaries and depreciation [1]